Usana Health Sciences
USNA
145 hedge funds and large institutions have $714M invested in Usana Health Sciences in 2017 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 66 increasing their positions, 35 reducing their positions, and 25 closing their positions.
89% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 35
21% more capital invested
Capital invested by funds: $593M → $714M (+$122M)
16% more call options, than puts
Call options by funds: $4.56M | Put options by funds: $3.92M
3.48% more ownership
Funds ownership: 41.98% → 45.46% (+3.5%)
6% less funds holding
Funds holding: 155 → 145 (-10)
28% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$11.5M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.89M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$6.77M |
| 4 |
Two Sigma Investments
New York
|
+$5.93M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$4.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$3.88M |
| 2 |
Charles Schwab
San Francisco,
California
|
-$2.03M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.53M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$1.44M |
| 5 |
AG
Algert Global
San Francisco,
California
|
-$1.26M |
USNA Hedge Fund Activity: Q2 2017 in Review
145 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2017, worth a combined $714M — up 21% from $593M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of USNA and 18 opened new positions — a net loss of 7 holders — while 35 trimmed existing stakes and 66 added.
The largest buyer was Renaissance Technologies, adding an estimated $11.5M. The largest seller was Morgan Stanley, cutting an estimated $3.88M.
- 145 institutional investors held Usana Health Sciences (USNA) as of Q2 2017, down from 155 in Q1 2017.
- Funds reported $714M of Usana Health Sciences stock for Q2 2017, up 21% quarter-over-quarter.
- 18 funds opened new Usana Health Sciences positions in Q2 2017 and 25 closed out, a net change of -7 holders.
- The largest Usana Health Sciences buyer in Q2 2017 was Renaissance Technologies, an estimated $11.5M added.
- The largest Usana Health Sciences seller in Q2 2017 was Morgan Stanley, an estimated $3.88M sold.
Based on aggregated 13F filings for Q2 2017.